Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Impella registry analyses report lower mortality than CHIP-BCIS3 in high-risk PCI


Intranasal foralumab reduces microglial activation in Phase IIa progressive MS trial


Shockwave Javelin IVL catheter shows positive results in pivotal FORWARD CAD study


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Mass Spectrometry – an Essential Tool for Characterization of Monoclonal Antibodies during Development

Presented by Dr Wei Xu & Dr Henry Shion
03rd February 2016


Just in Time Release of CAR T Cell Therapies

Presented by Irving Ford, Head of CAR T QC Laboratories at Celgene and Lori Daane, Pharma Microbiology Scientific Director at bioMérieux
11th November 2019


CCAB: Addressing the risk of microbial impurities in Biologics and certain Advanced Therapy Medicinal Products (ATMPs)

Presented by Dr Friedrich von Wintzingerode, QC Lead iNeST (individual Neoepitope Specific Therapy), Roche and Nahuel Paolini, PhD, Sanquin Reagents
28th March 2022


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia